APA

Shahbazi M., Ebadi H., Fathi D., Roshandel D., Mohamadhosseni M., Tahmasebi A., Shahbazi S., Zamani M. & Rashidbaghan A. (20110121). HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Shahbazi M, Ebadi H, Fathi D, Roshandel D, Mohamadhosseni M, Tahmasebi A, Shahbazi S, Zamani M and Rashidbaghan A. 20110121. HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Shahbazi M., Ebadi H., Fathi D., Roshandel D., Mohamadhosseni M., Tahmasebi A., Shahbazi S., Zamani M. and Rashidbaghan A. (20110121). HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Shahbazi M, Ebadi H, Fathi D, Roshandel D, Mohamadhosseni M, Tahmasebi A, Shahbazi S, Zamani M and Rashidbaghan A. HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. : Multiple sclerosis (Houndmills, Basingstoke, England). 20110121.